Mioepiteliomi maligni dei tessuti molli e ossei, casistica dell’Istituto Ortopedico Rizzoli

Title

Code

Malignant Mioepithelyoma

Type

Osservazionale

Start Year

2022

Status

Terminato

Principal Investigator

051-6445516

alessandra.longhi@ior.it

Longhi Alessandra, MD

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies

Operational unit that carry out the study

complex unit

Osteoncologia, Sarcomi dell'osso e dei tessuti molli, e Terapie Innovative

Director

Ibrahim Toni, BSc, MSc, MD, PhD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. Malignant Mioepithelyoma

Monday 29 August 2022, 10:35

PG0013130_2022_Malignant Mioepithelyoma.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Mioepiteliomi maligni dei tessuti molli e ossei, casistica dell’Istituto Ortopedico Rizzoli

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Mioepiteliomi maligni dei tessuti molli e ossei, casistica dell’Istituto Ortopedico Rizzoli

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in